Immunoprecise Stock Market Sentiment

IPA
 Stock
  

USD 3.95  0.11  2.86%   

Immunoprecise investor sentiment overview provides quick insight into current market opportunities from investing in Immunoprecise Antibodies. The current market sentiment together Immunoprecise Antibodies' historical and current headlines can help investors to time the market. Many technical investors use Immunoprecise Antibodies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please see Immunoprecise Antibodies Hype Analysis, Immunoprecise Antibodies Correlation and Immunoprecise Antibodies Performance.
  
Refresh
Immunoprecise Antibodies stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Immunoprecise daily returns and investor perception about the current pice of Immunoprecise Antibodies as well as its diversification or hedging effects on your existing portfolios.

Immunoprecise Latest Sentiment Indicators

200 Day MA
5.43
Short Percent
0.0258
Short Ratio
14.43
Shares Short Prior Month
240.8 K
50 Day MA
4.87
52 Week Low
3.51
Shares Short
231.7 K
over a year ago at www.equities.com         
ImmunoPrecise Antibodies Ltd gains 9.8460 percent for June 11 - Equities.com
Equities News
over a year ago at www.equities.com         
ImmunoPrecise Antibodies Ltd falls -1.5150 percent for June 10 - Equities.com
Equities News
over a year ago at www.equities.com         
ImmunoPrecise Antibodies Ltd falls -7.4200 percent for June 08 - Equities.com
Equities News
over a year ago at www.equities.com         
ImmunoPrecise Antibodies Ltd falls -6.3860 percent for June 03 - Equities.com
Equities News
over a year ago at www.equities.com         
ImmunoPrecise Antibodies Ltd falls -1.5650 percent for June 02 - Equities.com
Equities News
over a year ago at www.streetinsider.com         
ImmunoPrecise Names Dr. Dion Neame to Strategic Advisory Board - StreetInsider.com
Street Insider News
over a year ago at finance.yahoo.com         
ImmunoPrecise Moves SARS-CoV-2 PolyTope Cocktail Programs Path Toward IND Filing - Yahoo Finance
Yahoo News
over a year ago at www.marketscreener.com         
ImmunoPrecise Antibodies Moves SARS-CoV-2 PolyTope Cocktail Programs Path Toward IND Filing - Market...
news
over a year ago at www.benzinga.com         
12 Health Care Stocks Moving In Mondays Intraday Session - Benzinga
benzinga news
over a year ago at finance.yahoo.com         
ImmunoPrecise Antibodies Stock Is Believed To Be Significantly Overvalued - Yahoo Finance
Yahoo News
over a year ago at finance.yahoo.com         
ImmunoPrecise Antibodies Announces Results from a Comprehensive Screening of 27 Proprietary Anti-SAR...
Yahoo News
There is far too much social signal, news, headlines, and media speculation about Immunoprecise Antibodies that is available to investors today. That information is available publicly through Immunoprecise media outlets and privately through word of mouth or via Immunoprecise internal channels. However, regardless of the origin, that massive amount of Immunoprecise data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Immunoprecise Antibodies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Immunoprecise Antibodies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Immunoprecise Antibodies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Immunoprecise Antibodies alpha.

Immunoprecise Antibodies Performance against DOW

 Price Growth (%)  
      Timeline 
1
EPS Reported06/22/2020
2
EPS Estimate07/31/2020
3
EPS Reported08/28/2020
4
EPS Estimate10/28/2020
5
EPS Reported12/21/2020
6
Other12/30/2020
7
Other01/06/2021
8
Other01/07/2021
9
EPS Estimate01/28/2021
10
Other02/03/2021
11
Other02/04/2021
12
Other02/08/2021
13
Other02/11/2021
14
Other02/19/2021
15
Other03/04/2021
16
ImmunoPrecise Antibodies Announces Results from a Comprehens...03/16/2021
17
EPS Reported03/17/2021
18
Other03/18/2021
19
Other03/25/2021
20
Other04/08/2021
21
Other04/21/2021
22
EPS Estimate04/30/2021
23
Other05/20/2021
24
Other05/25/2021
25
Other06/02/2021
26
Other06/15/2021
27
Other06/17/2021
28
Other06/22/2021
29
Other07/15/2021
30
Immunoprecise Stock Soars As COVID-19 Antibody Cocktail Show...07/22/2021
31
EPS Reported07/28/2021
32
Other08/04/2021
33
ImmunoPrecise Reports Financial Results and Recent Business ...09/03/2021
34
Other09/07/2021
35
Other09/08/2021
36
EPS Reported09/09/2021
37
Other10/07/2021
38
Other10/13/2021
39
ImmunoPrecise Antibodies Enters into At-The-Market Distribut...10/14/2021
40
EPS Estimate10/28/2021
41
Other10/29/2021
42
Other11/09/2021
43
Other11/12/2021
44
While shareholders of ImmunoPrecise Antibodies are in the bl...11/22/2021
45
Other11/24/2021
46
ImmunoPrecise Antibodies Update on its SARS-CoV-2 PolyTope M...11/29/2021
47
Other11/30/2021
48
Other12/07/2021
49
EPS Reported12/13/2021
50
Other12/20/2021
51
Other01/03/2022
52
ImmunoPrecise Antibodies Announces Grant of Stock Options Ne...01/11/2022
53
Other01/18/2022
54
EPS Estimate01/31/2022
55
Other03/08/2022
56
Other03/14/2022
57
EPS Reported03/16/2022
58
Other03/29/2022
59
Other04/12/2022
60
IPA Completes Acquisition of Belgian Technology Companies Bi...04/13/2022
61
Other04/14/2022
62
Other04/20/2022
63
ImmunoPrecise Antibodies Form 51-102F3 MATERIAL CHANGE REPOR...04/25/2022
64
IPAs Subsidiary BioStrand Secures Second VLAIO Research Gran...05/09/2022
Please see Immunoprecise Antibodies Hype Analysis, Immunoprecise Antibodies Correlation and Immunoprecise Antibodies Performance. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
90.4 M
Quarterly Revenue Growth YOY
0.066
Return On Assets
-0.19
Return On Equity
-0.43
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.